82 related articles for article (PubMed ID: 20345565)
1. Regional registry of patient alloantibodies: first-year experience.
Schwickerath V; Kowalski M; Menitove JE
Transfusion; 2010 Jul; 50(7):1465-70. PubMed ID: 20345565
[TBL] [Abstract][Full Text] [Related]
2. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Cox JV; Steane E; Cunningham G; Frenkel EP
Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
[TBL] [Abstract][Full Text] [Related]
3. Hyperhemolysis syndrome in anemia of chronic disease.
Darabi K; Dzik S
Transfusion; 2005 Dec; 45(12):1930-3. PubMed ID: 16371046
[TBL] [Abstract][Full Text] [Related]
4. Rates of delayed hemolytic transfusion reactions observed in a trauma center.
Hasan RA; Asif M; Tuott EE; Stansbury LG; Hess JR
Transfusion; 2021 Jul; 61(7):2035-2040. PubMed ID: 33983627
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
Tormey CA; Fisk J; Stack G
Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
[TBL] [Abstract][Full Text] [Related]
6. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.
Guastafierro S; Sessa F; Cuomo C; Tirelli A
Ann Hematol; 2004 May; 83(5):307-8. PubMed ID: 15064858
[TBL] [Abstract][Full Text] [Related]
7. An animal model for delayed hemolytic transfusion reactions.
Ness PM; Shirey RS; Weinstein MH; King KE
Transfus Med Rev; 2001 Oct; 15(4):305-17. PubMed ID: 11668437
[TBL] [Abstract][Full Text] [Related]
8. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis.
Vamvakas EC; Pineda AA; Reisner R; Santrach PJ; Moore SB
Transfusion; 1995 Jan; 35(1):26-32. PubMed ID: 7998064
[TBL] [Abstract][Full Text] [Related]
9. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions.
Winters JL; Richa EM; Bryant SC; Tauscher CD; Bendix BJ; Stubbs JR
Transfusion; 2010 Jul; 50(7):1444-52. PubMed ID: 20230534
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Natukunda B; Schonewille H; Ndugwa C; Brand A
Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
[TBL] [Abstract][Full Text] [Related]
11. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease.
Thoestesen LM; Rasmussen KL; Lauszus FF; Hansen CT; Titlestad KE; Larsen R
Acta Obstet Gynecol Scand; 2011 Jun; 90(6):636-41. PubMed ID: 21370997
[TBL] [Abstract][Full Text] [Related]
12. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
Schonewille H; van de Watering LM; Brand A
Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
[TBL] [Abstract][Full Text] [Related]
13. Delayed hemolytic transfusion reaction due to anti-Fyb caused by a primary immune response: a case study and a review of the literature.
Kim HH; Park TS; Oh SH; Chang CL; Lee EY; Son HC
Immunohematology; 2004; 20(3):184-6. PubMed ID: 15373650
[TBL] [Abstract][Full Text] [Related]
14. Management of hemolytic transfusion reactions.
Hendrickson JE; Fasano RM
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):704-709. PubMed ID: 34889404
[TBL] [Abstract][Full Text] [Related]
15. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
[TBL] [Abstract][Full Text] [Related]
16. The persistence and evanescence of blood group alloantibodies in men.
Tormey CA; Stack G
Transfusion; 2009 Mar; 49(3):505-12. PubMed ID: 19040411
[TBL] [Abstract][Full Text] [Related]
17. Cesarean section: is pretransfusion testing for red cell alloantibodies necessary?
Larsen R; Titlestad K; Lillevang ST; Thomsen SG; Kidholm K; Georgsen J
Acta Obstet Gynecol Scand; 2005 May; 84(5):448-55. PubMed ID: 15842209
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-CD32 alloantibody in donor plasma implicated in development of transfusion-related acute lung injury.
Nishimura M; Takanashi M; Okazaki H; Satake M
Cell Biochem Funct; 2007; 25(2):179-83. PubMed ID: 16287215
[TBL] [Abstract][Full Text] [Related]
19. Identification and evaluation of false-negative antibody screens.
Powers A; Chandrashekar S; Mohammed M; Uhl L
Transfusion; 2010 Mar; 50(3):617-21. PubMed ID: 19951323
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
